Survivin as a target for new anticancer interventions

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• Survivin, an inhibitor of apoptosis protein (IAP) family member, regulates cell division and apoptosis.
• Its anti-apoptotic function involves direct or indirect inhibition of caspases.
• Survivin is highly expressed in human neoplasms and contributes to tumor resistance against anticancer agents and radiation.

Purpose of the Study:

• To investigate survivin as a potential target for novel anticancer interventions.
• To evaluate the effects of down-regulating survivin expression or function on tumor cells.

Main Methods:

• Utilizing preclinical models (in vitro and in vivo) of various human tumor types.
• Employing strategies such as antisense oligonucleotides, dominant negative mutants, ribozymes, small interfering RNAs, and cyclin-dependent kinase inhibitors to down-regulate survivin.

Main Results:

• Down-regulation of survivin significantly increased the apoptotic rate in tumor cells.
• Reduced tumor growth potential was observed following survivin inhibition.
• Survivin-targeted strategies sensitized tumor cells to various chemotherapeutic drugs and gamma-irradiation.

Conclusions:

• Survivin is a critical factor in cancer cell survival and therapeutic resistance.
• Targeting survivin effectively enhances apoptosis and tumor cell sensitivity to anticancer treatments.
• Survivin represents a promising therapeutic target for developing new cancer interventions.